Stocksigma LogoStocksigma Logo

Vivanza Biosciences Board Meeting Scheduled for 3rd Nov'26 to Consider Q2 Results

Vivanza Biosciences Limited has scheduled a meeting of its Board of Directors on 3rd Nov'26 to consider and approve the unaudited standalone and

Vivanza Biosciences Board Meeting Scheduled for 3rd Nov'26 to Consider Q2 Results

Vivanza Biosciences Ltd 路 Intimation 路 03 Nov 2026, 5:30 am

Vivanza Biosciences Board Meeting Scheduled for 3rd Nov'26 to Consider Q2 Results Vivanza Biosciences Limited has scheduled a meeting of its Board of Directors on 3rd Nov'26 to consider and approve the unaudited standalone and consolidated financial results, along with the limited review report, for the quarter and half-year ended 30th Sep'26. In compliance with insider trading regulations, the trading window for dealing in company securities by designated persons and key managerial personnel remains closed until 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Vivanza Biosciences Ltd

All Vivanza Biosciences Ltd announcements